Wasatch Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
FFO
CIA
EP
Wasatch Advisors's DYN Position: Q3 2026 in Review
Wasatch Advisors reduced its Dyne Therapeutics (DYN) stake by 28% in Q3 2026, selling an estimated $2.84M and leaving 319,913 shares worth $5.15M. The position accounts for 0.04% of the portfolio, ranked #178.
Wasatch Advisors first reported a position in DYN in Q3 2022 and has held it in 17 quarters since. The position peaked at $33.7M in Q1 2023. 14 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Wasatch Advisors held 319,913 shares of Dyne Therapeutics worth $5.15M as of Q3 2026.
- Wasatch Advisors sold 123,755 Dyne Therapeutics shares in Q3 2026, an estimated $2.84M.
- Dyne Therapeutics made up 0.04% of Wasatch Advisors's portfolio in Q3 2026, its #178 holding.
- Wasatch Advisors first reported a position in Dyne Therapeutics in Q3 2022 and has held it in 17 quarters since.
- Wasatch Advisors's Dyne Therapeutics position peaked at $33.7M in Q1 2023.
- 14 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Wasatch Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.